Welcome to LifeSan Clinical Research, the premier, full-service clinical research division of Centaur Pharmaceuticals Pvt. Ltd. Based in Mumbai, India’s financial and commercial hub, we have delivered world-class clinical research solutions to global partners since 2008.

We combine scientific precision with an unyielding commitment to quality, ensuring your molecules seamlessly meet global standards Our Core Expertise

• BA/BE Excellence: Advanced Bioavailability and Bioequivalence studies conducted across diverse male and female subject groups
• Late-Phase Trials: End-to-end management and execution of Phase II, III, and IV clinical trials.
• In-Vitro studies: IVRT, IVPT, Enteral Tube Feeding studies
• Biometrics & Statistics: Comprehensive data services delivering fully CDISC-compliant datasets ready for international submission.

An Unrivaled Regulatory Track Record

• Your regulatory peace of mind is our top priority. Our systems, facilities, and data integrity consistently withstand the world's most rigorous audits.
• 9 USFDA Inspections: Flawless history with our most recent June 2025 inspection resulting in a completely "clean inspection"—zero observations, zero discussion items, and zero recommendations.
• MHRA Inspections: Two successful MHRA inspection with most recent inspection in January 2026 reiterating strict adherence to regulations
• Global Accreditations: Inspected and approved by premier international bodies including the USFDA, EMA, MHRA, SAHPRA, ISP-Chile, NPRA (Malaysia), and CDSCO (India) and GCC (Oman).
• Worldwide Acceptance: Data generated at LifeSan successfully supports regulatory submissions to the TGA (Australia), Health Canada, and agencies across the CIS region.

Why Choose LifeSan?
At LifeSan, we accelerate your path to market by merging clinical precision, strict compliance, and global credibility. Partner with us for research you can trust.